Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Anette Jørgensen"'
Autor:
Allan Riis, Emma Louise Karran, Janus Laust Thomsen, Anette Jørgensen, Søren Holst, Nanna Rolving
Publikováno v:
BMC Musculoskeletal Disorders, Vol 21, Iss 1, Pp 1-9 (2020)
Abstract Background According to clinical guidelines, advice to stay active despite experiencing pain is recommended to patients with non-specific low back pain (LBP). However, not all patients receive guideline-concordant information and advice, and
Externí odkaz:
https://doaj.org/article/e2eaf95703d94fdc8e2b2dacd8e64e62
Publikováno v:
BMC Musculoskeletal Disorders, Vol 18, Iss 1, Pp 1-8 (2017)
Abstract Background To evaluate whether clinical, radiographic or MRI findings are associated with long term risk for total knee arthroplasty (TKA) in persons with knee osteoarthritis. Methods We performed a follow-up analysis of 100 persons with kne
Externí odkaz:
https://doaj.org/article/482825900dfb424d8c4b0ccee81d90c7
Autor:
Anette Jørgensen, Allan Riis, Søren Holst, Nanna Rolving, Emma L. Karran, Janus Laust Thomsen
Publikováno v:
Riis, A, Karran, E L, Thomsen, J L, Jørgensen, A, Holst, S & Rolving, N 2020, ' The association between believing staying active is beneficial and achieving a clinically relevant functional improvement after 52 weeks : a prospective cohort study of patients with chronic low back pain in secondary care ', BMC Musculoskeletal Disorders, vol. 21, no. 1, 47 . https://doi.org/10.1186/s12891-020-3062-6
BMC Musculoskeletal Disorders, Vol 21, Iss 1, Pp 1-9 (2020)
BMC Musculoskeletal Disorders
BMC Musculoskeletal Disorders, Vol 21, Iss 1, Pp 1-9 (2020)
BMC Musculoskeletal Disorders
Background According to clinical guidelines, advice to stay active despite experiencing pain is recommended to patients with non-specific low back pain (LBP). However, not all patients receive guideline-concordant information and advice, and some pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4b8bdc6d67a7d81d93a3dcb482cc5f7
https://vbn.aau.dk/ws/files/320397865/Riis_et_al_2020_The_association_between_believing_staying_active_is_beneficial_and_achieving_a_clinically_relevant_functional_improvement_after_52_weeks.pdf
https://vbn.aau.dk/ws/files/320397865/Riis_et_al_2020_The_association_between_believing_staying_active_is_beneficial_and_achieving_a_clinically_relevant_functional_improvement_after_52_weeks.pdf
Autor:
Kristian Stengaard-Pedersen, Torkell Ellingsen, Hanne Merete Lindegaard, Peter Junker, Anette Jørgensen, Julia S. Johansen, Lykke Midtbøll Ørnbjerg, Tine Lottenburger, Rebecca Bolce, Cecilie Heegaard Brahe, Asta Linauskas, X Wang, Nadine Defranoux, Eric H. Sasso, Palle Ahlquist, Johnny Lillelund Raun, Mikkel Østergaard, Sophine B. Krintel, Ib Hansen, Christian Gytz Ammitzbøll, Kim Hørslev-Petersen, Annette Schlemmer, Merete Lund Hetland, Mette Yde Dam
Publikováno v:
Brahe, C H, Østergaard, M, Johansen, J S, Defranoux, N, Wang, X, Bolce, R, Sasso, E, Ørnbjerg, L, Hørslev-Petersen, K, Stengaard-Pedersen, K, Junker, P, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C, Jørgensen, A, Krintel, S, Raun, J & Hetland, M 2019, ' Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis : a post-hoc study of the OPERA trial ', Scandinavian Journal of Rheumatology, vol. 48, no. 1, pp. 9-16 . https://doi.org/10.1080/03009742.2018.1464206
Brahe, C H, Østergaard, M, Johansen, J S, Defranoux, N, Wang, X, Bolce, R, Sasso, E H, Ørnbjerg, L M, Hørslev-Petersen, K, Stengaard-Pedersen, K, Junker, P, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C, Jørgensen, A, Krintel, S B, Raun, J & Hetland, M L 2019, ' Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis : a post-hoc study of the OPERA trial ', Scandinavian Journal of Rheumatology, vol. 48, no. 1, pp. 9-16 . https://doi.org/10.1080/03009742.2018.1464206
Brahe, C H, Østergaard, M, Johansen, J S, Defranoux, N, Wang, X, Bolce, R, Sasso, E H, Ørnbjerg, L M, Hørslev-Petersen, K, Stengaard-Pedersen, K, Junker, P, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C, Jørgensen, A, Krintel, S B, Raun, J & Hetland, M L 2019, ' Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis : a post-hoc study of the OPERA trial ', Scandinavian Journal of Rheumatology, vol. 48, no. 1, pp. 9-16 . https://doi.org/10.1080/03009742.2018.1464206
OBJECTIVES: Measurement of serum biomarkers at disease onset may improve prediction of disease course in patients with early rheumatoid arthritis (RA). We evaluated the multi-biomarker disease activity (MBDA) score and early changes in MBDA score for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea3dba9f21c328597c172b320aec3e4d
https://pubmed.ncbi.nlm.nih.gov/29985080
https://pubmed.ncbi.nlm.nih.gov/29985080
Publikováno v:
Nielsen, F K, Egund, N, Jørgensen, A & Jurik, A G 2017, ' Risk factors for joint replacement in knee osteoarthritis; a 15-year follow-up study ', B M C Musculoskeletal Disorders, vol. 18, no. 1, pp. 510 . https://doi.org/10.1186/s12891-017-1871-z
BMC Musculoskeletal Disorders, Vol 18, Iss 1, Pp 1-8 (2017)
BMC Musculoskeletal Disorders
BMC Musculoskeletal Disorders, Vol 18, Iss 1, Pp 1-8 (2017)
BMC Musculoskeletal Disorders
Background To evaluate whether clinical, radiographic or MRI findings are associated with long term risk for total knee arthroplasty (TKA) in persons with knee osteoarthritis. Methods We performed a follow-up analysis of 100 persons with knee osteoar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::693930e16f1489a3e7440f8948eceb2f
https://pure.au.dk/portal/da/publications/risk-factors-for-joint-replacement-in-knee-osteoarthritis-a-15year-followup-study(2e866f55-ba7e-4a19-8294-ec1804ef47e2).html
https://pure.au.dk/portal/da/publications/risk-factors-for-joint-replacement-in-knee-osteoarthritis-a-15year-followup-study(2e866f55-ba7e-4a19-8294-ec1804ef47e2).html
Autor:
Peter Junker, Tove Lorenzen, Tonny Jensen, Mikkel Østergaard, Natalia Manilo, Henning Bliddal, Kristian Stengaard-Pedersen, Lykke Midtbøll Ørnbjerg, Tine Lottenburger, Marcin Ryszard Kowalski, Hans Christian Horn, Hanne Merete Lindegaard, I. Hansen, Ole Slot, Anette Jørgensen, Inger Lauge Johansen, Palle Ahlquist, Asta Linauskas, Annette Schlemmer, Lars Kjær Nielsen, Torkell Ellingsen, Peter Mosborg Pedersen, O Majgaard, Christian Gytz Ammitzbøll, Mette Yde Dam, Johnny Lillelund Raun, Merete Lund Hetland, Kim Hørslev-Petersen, Henrik Skjødt, Sophine B. Krintel
Publikováno v:
Ørnbjerg, L M, Østergaard, M, Jensen, T, Hørslev-Petersen, K, Stengaard-Pedersen, K, Junker, P, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Hetland, M L, Slot, O, Nielsen, L K, Skjødt, H, Majgaard, O, Lorenzen, T, Horn, H C, Kowalski, M, Johansen, I L, Pedersen, P M, Manilo, N, Bliddal, H & OPERA Study Group 2017, ' Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial ', Clinical Rheumatology, vol. 36, no. 4, pp. 781-789 . https://doi.org/10.1007/s10067-016-3489-1
Ørnbjerg, L M, Østergaard, M, Jensen, T, Hørslev-Petersen, K, Stengaard-Pedersen, K, Junker, P, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Hetland, M L, OPERA Study Group & Lorenzen, T 2017, ' Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial ', Clinical Rheumatology, vol. 36, no. 4, pp. 781-789 . https://doi.org/10.1007/s10067-016-3489-1
Ørnbjerg, L M, Østergaard, M, Jensen, T, Hørslev-Petersen, K, Stengaard-Pedersen, K, Junker, P, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Hetland, M L, OPERA Study Group, Slot, O, Nielsen, L K, Skjødt, H, Majgaard, O, Lorenzen, T, Horn, H C, Kowalski, M, Johansen, I L, Pedersen, P M, Manilo, N & Bliddal, H 2017, ' Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab : a substudy of the optimized treatment algorithm in early RA (OPERA) trial ', Clinical Rheumatology, vol. 36, no. 4, pp. 781–789 . https://doi.org/10.1007/s10067-016-3489-1
Ørnbjerg, L M, Østergaard, M, Jensen, T, Hørslev-Petersen, K, Stengaard-Pedersen, K, Junker, P, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Hetland, M L, OPERA Study Group & Lorenzen, T 2017, ' Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab-a substudy of the optimized treatment algorithm in early RA (OPERA) trial ', Clinical Rheumatology, vol. 36, no. 4, pp. 781-789 . https://doi.org/10.1007/s10067-016-3489-1
Ørnbjerg, L M, Østergaard, M, Jensen, T, Hørslev-Petersen, K, Stengaard-Pedersen, K, Junker, P, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Hetland, M L, OPERA Study Group, Slot, O, Nielsen, L K, Skjødt, H, Majgaard, O, Lorenzen, T, Horn, H C, Kowalski, M, Johansen, I L, Pedersen, P M, Manilo, N & Bliddal, H 2017, ' Hand bone loss in early rheumatoid arthritis during a methotrexate-based treat-to-target strategy with or without adalimumab : a substudy of the optimized treatment algorithm in early RA (OPERA) trial ', Clinical Rheumatology, vol. 36, no. 4, pp. 781–789 . https://doi.org/10.1007/s10067-016-3489-1
This study aims to investigate 1-year hand bone loss (HBL 1-year) in early rheumatoid arthritis (RA) patients treated with a methotrexate (MTX) and intra-articular triamcinolone treat-to-target strategy +/− adalimumab and to determine if HBL 6month
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c1278219bd037cb38835e551f2c6113
https://vbn.aau.dk/da/publications/5f92c4a2-ba8f-4497-bb5f-3f87c3f31dd4
https://vbn.aau.dk/da/publications/5f92c4a2-ba8f-4497-bb5f-3f87c3f31dd4
Autor:
Mikkel Østergaard, Peter Junker, Hans Christian Horn, Asta Linauskas, Ib Tønder Hansen, Mette Bjørndal Axelsen, Palle Ahlquist, Hanne Merete Lindegaard, Julia S. Johansen, Niels Steen Krogh, Merete Lund Hetland, Iris Eshed, Johnny Lillelund Raun, Sophine B. Krintel, Jan Pødenphant, Mette Yde Dam, Kim Hørslev-Petersen, Kristian Stengaard-Pedersen, Anette Jørgensen, Christian Gytz Ammitzbøll, J. Møller, Torkell Ellingsen, Annette Schlemmer
Publikováno v:
Axelsen, M B, Eshed, I, Hørslev-Petersen, K, Stengaard-Pedersen, K, Hetland, M L, Møller, J, Junker, P, Pødenphant, J, Schlemmer, A, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Dam, M Y, Hansen, I, Horn, H C, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Krogh, N S, Johansen, J S, Ostergaard, M & OPERA study group 2015, ' A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis : Results from the OPERA randomised controlled trial ', Annals of the Rheumatic Diseases, vol. 74, no. 5, pp. 867-875 . https://doi.org/10.1136/annrheumdis-2013-204537
Axelsen, M B, Eshed, I, Hørslev-Petersen, K, Stengaard-Pedersen, K, Hetland, M L, Møller, J, Junker, M P, Pødenphant, J, Schlemmer, A, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Dam, M Y, Hansen, I, Horn, H C, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Krogh, N S, Johansen, J S, Østergaard, M & OPERA Study Group 2014, ' A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis : results from the OPERA randomised controlled trial ', Annals of the Rheumatic Diseases . https://doi.org/10.1136/annrheumdis-2013-204537
Axelsen, M B, Eshed, I, Hørslev-Petersen, K, Stengaard-Pedersen, K, Hetland, M L, Møller, J R, Junker, P, Pødenphant, J, Schlemmer, A, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Dam, M Y, Hansen, I T, Horn, H C, Ammitzbøll, C G, Jørgensen, A J, Krintel, S B, Raun, J, Krogh, N S, Johansen, J S, Ostergaard, M & OPERA Study Group 2015, ' A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial ', Annals of the Rheumatic Diseases, vol. 74, no. 5, pp. 867-875 . https://doi.org/10.1136/annrheumdis-2013-204537
Axelsen, M B, Eshed, I, Hørslev-Petersen, K, Stengaard-Pedersen, K, Hetland, M L, Møller, J, Junker, M P, Pødenphant, J, Schlemmer, A, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Dam, M Y, Hansen, I, Horn, H C, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Krogh, N S, Johansen, J S, Østergaard, M & OPERA Study Group 2014, ' A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis : results from the OPERA randomised controlled trial ', Annals of the Rheumatic Diseases . https://doi.org/10.1136/annrheumdis-2013-204537
Axelsen, M B, Eshed, I, Hørslev-Petersen, K, Stengaard-Pedersen, K, Hetland, M L, Møller, J R, Junker, P, Pødenphant, J, Schlemmer, A, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Dam, M Y, Hansen, I T, Horn, H C, Ammitzbøll, C G, Jørgensen, A J, Krintel, S B, Raun, J, Krogh, N S, Johansen, J S, Ostergaard, M & OPERA Study Group 2015, ' A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial ', Annals of the Rheumatic Diseases, vol. 74, no. 5, pp. 867-875 . https://doi.org/10.1136/annrheumdis-2013-204537
OBJECTIVES: To investigate whether a treat-to-target strategy with methotrexate and intra-articular glucocorticosteroid injections suppresses MRI inflammation and halts structural damage progression in patients with early rheumatoid arthritis (ERA),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21c0fb21d4b5dc46f7a4d94759490741
https://doi.org/10.1136/annrheumdis-2013-204537
https://doi.org/10.1136/annrheumdis-2013-204537
Autor:
Ib Tønder Hansen, Kristian Stengaard-Pedersen, Julia S. Johansen, Peter Junker, Hanne Merete Lindegaard, Mikkel Østergaard, Torkell Ellingsen, Anette Jørgensen, Merete Lund Hetland, Hans Christian Horn, Sophine B. Krintel, Johnny Lillelund Raun, Mette Yde Dam, Christian Gytz Ammitzbøll, Palle Ahlquist, Annette Schlemmer, Jan Pødenphant, Opera study-group, Asta Linauskas, Kim Hørslev-Petersen
Publikováno v:
Hørslev-Petersen, K, Hetland, M L, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Horn, H C, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Johansen, J S, Ostergaard, M, Stengaard-Pedersen, K & OPERA study-group 2014, ' Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study : An investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial ', Annals of the Rheumatic Diseases, vol. 73, no. 4, pp. 654-661 . https://doi.org/10.1136/annrheumdis-2012-202735
Hørslev-Petersen, K, Hetland, M L, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Tønder Hansen, I, Horn, H C, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Johansen, J S, Østergaard, M, Stengaard-Pedersen, K & OPERA Study Group 2013, ' Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study : an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial ', Annals of the Rheumatic Diseases . https://doi.org/10.1136/annrheumdis-2012-202735
OPERA Study Group 2014, ' Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life : The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial ', Annals of the Rheumatic Diseases, vol. 73, no. 4, pp. 654-661 . https://doi.org/10.1136/annrheumdis-2012-202735
Hørslev-Petersen, K, Hetland, M L, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Tønder Hansen, I, Horn, H C, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Johansen, J S, Østergaard, M, Stengaard-Pedersen, K & OPERA Study Group 2013, ' Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study : an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial ', Annals of the Rheumatic Diseases . https://doi.org/10.1136/annrheumdis-2012-202735
OPERA Study Group 2014, ' Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life : The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial ', Annals of the Rheumatic Diseases, vol. 73, no. 4, pp. 654-661 . https://doi.org/10.1136/annrheumdis-2012-202735
OBJECTIVES: An investigator-initiated, double-blinded, placebo-controlled, treat-to-target protocol (Clinical Trials:NCT00660647) studied whether adalimumab added to methotrexate and intra-articular triamcinolone as first-line treatment in early rheu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e10e52e936fd7f22b860f244fa2336f
https://doi.org/10.1136/annrheumdis-2012-202735
https://doi.org/10.1136/annrheumdis-2012-202735
Autor:
Hanne Merete Lindegaard, Johnny Lillelund Raun, Inger Marie Jensen Hansen, Peter Junker, Merete Lund Hetland, Torkell Ellingsen, Kim Hørslev-Petersen, S B Krintel, Christian Gytz Ammitzbøll, Palle Ahlquist, Kristian Stengaard-Pedersen, Annette Schlemmer, Asta Linauskas, Julia S. Johansen, Jan Pødenphant, Opera study-group, Lykke Midtbøll Ørnbjerg, Tine Lottenburger, Anette Jørgensen, Mikkel Østergaard, Mette Yde Dam
Publikováno v:
Hørslev-Petersen, K, Hetland, M L, Ørnbjerg, L M, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Johansen, J S, Østergaard, M, Stengaard-Pedersen, K & OPERA Study-Group 2016, ' Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction : a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA) ', Annals of the Rheumatic Diseases, vol. 75, no. 9, pp. 1645-1653 . https://doi.org/10.1136/annrheumdis-2015-208166
Hørslev-Petersen, K, Hetland, M L, Ørnbjerg, L M, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I T, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Johansen, J S, Østergaard, M, Stengaard-Pedersen, K & OPERA Study Group 2016, ' Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction : a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA) ', Annals of the Rheumatic Diseases, vol. 75, no. 9, pp. 1645-1653 . https://doi.org/10.1136/annrheumdis-2015-208166
Hørslev-Petersen, K, Hetland, M L, Ørnbjerg, L M, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Johansen, J S, Østergaard, M, Stengaard-Pedersen, K & OPERA Study Group 2016, ' Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction : a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA) ', Annals of the Rheumatic Diseases, vol. 75, no. 9, pp. 1645-1653 . https://doi.org/10.1136/annrheumdis-2015-208166
Hørslev-Petersen, K, Hetland, M L, Ørnbjerg, L M, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I T, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Johansen, J S, Østergaard, M, Stengaard-Pedersen, K & OPERA Study Group 2016, ' Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction : a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA) ', Annals of the Rheumatic Diseases, vol. 75, no. 9, pp. 1645-1653 . https://doi.org/10.1136/annrheumdis-2015-208166
Hørslev-Petersen, K, Hetland, M L, Ørnbjerg, L M, Junker, P, Pødenphant, J, Ellingsen, T, Ahlquist, P, Lindegaard, H, Linauskas, A, Schlemmer, A, Dam, M Y, Hansen, I, Lottenburger, T, Ammitzbøll, C G, Jørgensen, A, Krintel, S B, Raun, J, Johansen, J S, Østergaard, M, Stengaard-Pedersen, K & OPERA Study Group 2016, ' Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction : a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA) ', Annals of the Rheumatic Diseases, vol. 75, no. 9, pp. 1645-1653 . https://doi.org/10.1136/annrheumdis-2015-208166
ObjectivesTo study clinical and radiographic outcomes after withdrawing 1 year's adalimumab induction therapy for early rheumatoid arthritis (eRA) added to a methotrexate and intra-articular triamcinolone hexacetonide treat-to-target strategy (NCT006
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac2d7af6f3aa2b382362ad99b1a826d9
https://vbn.aau.dk/da/publications/cbe84af7-b9ff-46d8-be4f-4290c472866c
https://vbn.aau.dk/da/publications/cbe84af7-b9ff-46d8-be4f-4290c472866c
Autor:
Mette Yde Dam, Christian Gytz Ammitzbøll, Lykke Midtbøll Ørnbjerg, Tine Lottenburger, Annette Schlemmer, Mikkel Østergaard, Torkell Ellingsen, Hanne Merete Lindegaard, Asta Linauskas, Peter Junker, Palle Ahlquist, Anette Jørgensen, Kim Hørslev-Petersen, Inger Marie Jensen Hansen, Sophine B. Krintel, Kristian Stengaard-Pedersen, Tonny Jensen, Merete Lund Hetland, Johnny Lillelund Raun
Publikováno v:
Annals of the Rheumatic Diseases. 75:633.1-633
Background Rheumatoid arthritis (RA) is characterised by progressive destruction of joint bone and loss of periarticular bone mineral. Hand bone loss (HBL) measured by Digital X-ray Radiogrammetry (DXR) has been proposed as a sensitive outcome measur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97864374008c38ab8a7f3c9e7a181160
https://doi.org/10.1136/annrheumdis-2016-eular.3000
https://doi.org/10.1136/annrheumdis-2016-eular.3000